Statement of Shareholders' Equity (Deficiency) (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit during Development Stage
Shareholders' deficiency, Beginning balance at Jan. 31, 2012	$ (90,807)	$ 1,233	$ 81,323	$ (173,363)	$ 0
Common stock, shares outstanding, Beginning balance at Jan. 31, 2012		1,233,853
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(82,951)			(39,675)	(43,276)
Shareholders' deficiency, Ending balance at Jan. 31, 2013	(173,758)	1,233	81,323	(213,038)	(43,276)
Common stock, shares outstanding, Ending balance at Jan. 31, 2013	1,233,853	1,233,853
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(85,150)			0	(85,150)
Shareholders' deficiency, Ending balance at Jan. 31, 2014	$ (258,908)	$ 1,233	$ 81,323	$ (213,038)	$ (128,426)
Common stock, shares outstanding, Ending balance at Jan. 31, 2014	1,233,853	1,233,853